Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity ; volume:9 ; number:1 ; day:19 ; month:12 ; year:2012 ; pages:1-16 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (19.12.2012), 1-16, 12.2012
- Creator
-
Harati, Rania
- Contributor
-
Villégier, Anne-Sophie
Banks, William A.
Mabondzo, Aloise
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-273
- URN
-
urn:nbn:de:1111-2016032331432
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Harati, Rania
- Villégier, Anne-Sophie
- Banks, William A.
- Mabondzo, Aloise
- SpringerLink (Online service)
Other Objects (12)
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
Differences in P-glycoprotein activity in human and rodent blood–brain barrier assessed by mechanistic modelling
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
In silico the blood-brain barrier permeation and P-glycoprotein interaction modeling of various chemical compounds and cyclodextrin-formulated drugs
P-glycoprotein transporter in drug development
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein